Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J L Haug
Sorafenib, a Dual Raf Kinase/Vascular Endothelial Growth Factor Receptor Inhibitor Has Significant Anti-Myeloma Activity and Synergizes With Common Anti-Myeloma Drugs
Oncogene
Cancer Research
Genetics
Molecular Biology
Related publications
Phase II Study of SU5416, a Small Molecule Vascular Endothelial Growth Factor Tyrosine Kinase Receptor Inhibitor, in Patients With Refractory Multiple Myeloma
Clinical Cancer Research
Cancer Research
Oncology
Anti-Vascular Endothelial Growth Factor for Neovascular Glaucoma
Cochrane Database of Systematic Reviews
The Tyrosine Kinase Inhibitor Cediranib Blocks Ligand-Induced Vascular Endothelial Growth Factor Receptor-3 Activity and Lymphangiogenesis
Cancer Research
Cancer Research
Oncology
Anti-Myeloma Activity of MELK Inhibitor OTS167: Effects on Drug-Resistant Myeloma Cells and Putative Myeloma Stem Cell Replenishment of Malignant Plasma Cells
Blood Cancer Journal
Oncology
Hematology
Ten Years of Anti-Vascular Endothelial Growth Factor Therapy
Nature Reviews Drug Discovery
Medicine
Drug Discovery
Pharmacology
Anti-Vascular Endothelial Growth Factor for Proliferative Diabetic Retinopathy
Vascular Endothelial Growth Factor Receptor 3 Is a Novel Marker Differing CD138-positive and CD138-negative Multiple Myeloma Cells
British Journal of Haematology
Hematology
A Recombinant Mutant Vascular Endothelial Growth Factor-C That Has Lost Vascular Endothelial Growth Factor Receptor-2 Binding, Activation, and Vascular Permeability Activities
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Inhibition of Chronic and Acute Skin Inflammation by Treatment With a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor
American Journal of Pathology
Forensic Medicine
Pathology
